TACRONOL (Tacrolimus (0.1% w/w))

Tacronol 0.1% Cream is indicated for the management of eczema, also referred to as atopic dermatitis. This topical treatment functions by inhibiting the action of specific immune cells responsible for causing skin inflammation, which manifests as redness and swelling. By reducing this inflammatory response, it alleviates associated symptoms such as itching and enhances the appearance of rashes linked to atopic dermatitis. The cream is intended for external application only, typically recommended to be used two to four times daily on the affected skin areas, or as directed by a healthcare professional. It should be applied gently and uniformly until fully absorbed, avoiding excessive frequency of use. It is important not to cover the area with dressings or bandages unless instructed by a doctor. If there is no visible improvement after two weeks of treatment, or if the skin condition worsens, it is essential to consult your healthcare provider for further assessment. While Tacronol can be beneficial, potential adverse effects may occur and should be monitored. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.